The global toxicity testing outsourcing market size is expected to reach USD 6.78 billion by 2030, registering a CAGR of 9.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing attrition rate in preclinical studies is stimulating demand for the outsourcing of preclinical studies to the CROs, which offer end-to-end services including toxicology testing services. Also, rising growth and innovation in pharmaceutical and biopharmaceutical companies, augment in R&D, and increasing ethical concerns about animal use are driving the enlargement of the market.
COVID-19 has significantly impacted the market for toxicity testing outsourcing. During the crisis, vaccine, medical device, and biologic contract research and manufacturing service providers played a predominant role in meeting the needs of pharmaceutical companies, biotech companies, and other end users. These organizations have been actively working towards the development of healthcare products that can be used as a treatment for patients, suffering from COVID-19 with mild symptoms, since the end of 2019. And these products require toxicity testing at each stage to assess safety and effectiveness, thus contributing to market growth.
Companies in the pharmaceutical and biopharmaceutical industries operate in an environment that is becoming more complex to understand. Improvements in many therapeutic areas, as well as the emergence of new types of therapies such as genetically targeted therapies, biologics, stem cell therapies, and other treatment modalities, have resulted in more complex development and regulatory pathways. To develop a treatment that is secure and efficient, it is necessary to do toxicity testing at each stage, which is boosting the market's growth.
Request a free sample copy or view the report summary: Toxicity Testing Outsourcing Market Report
The method segment is segmented into in vitro and in vivo. In vitro accounted for the largest market share of 57.7% in 2021
The academic and research institutes segment is anticipated to grow at the fastest CAGR of 9.6% during the forecast period. This is due to the rising research on novel drugs intended for various therapeutic areas
Asia Pacific accounted for the fastest CAGR of 11.3% during the forecast period, owing to the cost efficiency offered by CROs and CDMOs in countries such as India and China
In February 2022, Charles River Laboratories International, Inc. announced an expansion of its manufacturing capacity in Brunt wood SciTech’s Alderley Park in Europe
Grand View Research has segmented the global toxicity testing outsourcing market based on the method, GLP type, end-use, and region:
Toxicity Testing Outsourcing Method Outlook (Revenue, USD Million, 2018 - 2030)
In vitro
In vivo
Toxicity Testing Outsourcing GLP Type Outlook (Revenue, USD Million, 2018 - 2030)
GLP
Non GLP
Toxicity Testing Outsourcing End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical and Biopharmaceutical Companies
Academic and Research Institutes
Others
Toxicity Testing Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
List of Key Players in Toxicity Testing Outsourcing Market
Euro fins Scientific
SGS SA
Charles River Laboratories
Thermo Fisher Scientific, Inc.
Intertek Group plc,
Catalent, Inc.
ICON plc.
Med pace
Labcorp Drug Development
Wuxi AppTec
"The quality of research they have done for us has been excellent..."